Ferguson Wellman Capital Management’s CONSTELLATION ENRGY GP(HLDG CO CEG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-611
Closed -$216K 418
2025
Q4
$216K Sell
611
-1
-0.2% -$353 ﹤0.01% 344
2025
Q3
$201K Buy
+612
New +$201K ﹤0.01% 349
2024
Q4
Sell
-1,695
Closed -$441K 370
2024
Q3
$441K Sell
1,695
-51
-3% -$13.3K 0.01% 263
2024
Q2
$350K Sell
1,746
-3,188
-65% -$638K 0.01% 285
2024
Q1
$912K Buy
4,934
+23
+0.5% +$4.25K 0.02% 201
2023
Q4
$574K Hold
4,911
0.01% 242
2023
Q3
$536K Buy
4,911
+19
+0.4% +$2.07K 0.01% 238
2023
Q2
$448K Sell
4,892
-11
-0.2% -$1.01K 0.01% 263
2023
Q1
$385K Buy
4,903
+33
+0.7% +$2.59K 0.01% 274
2022
Q4
$420K Buy
4,870
+112
+2% +$9.66K 0.01% 266
2022
Q3
$396K Sell
4,758
-597
-11% -$49.7K 0.02% 240
2022
Q2
$307K Buy
5,355
+584
+12% +$33.5K 0.01% 267
2022
Q1
$268K Buy
+4,771
New +$268K 0.01% 298

Other funds holding CEG

Ferguson Wellman Capital Management's CEG Position: Q1 2026 in Review

Ferguson Wellman Capital Management sold out of CONSTELLATION ENRGY GP(HLDG CO (CEG) in Q1 2026, closing a stake of 611 shares — an estimated $216K sold.

Ferguson Wellman Capital Management first reported a position in CEG in Q1 2022 and held it in 13 quarters. The position peaked at $912K in Q1 2024. 2 funds tracked by Wall St. Rank hold CEG as of Q1 2026.

  • Ferguson Wellman Capital Management reported no remaining CONSTELLATION ENRGY GP(HLDG CO position as of Q1 2026 after selling out during the quarter.
  • Ferguson Wellman Capital Management sold 611 CONSTELLATION ENRGY GP(HLDG CO shares in Q1 2026, an estimated $216K.
  • Ferguson Wellman Capital Management first reported a position in CONSTELLATION ENRGY GP(HLDG CO in Q1 2022 and held it in 13 quarters.
  • Ferguson Wellman Capital Management's CONSTELLATION ENRGY GP(HLDG CO position peaked at $912K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held CONSTELLATION ENRGY GP(HLDG CO as of Q1 2026.

Based on Ferguson Wellman Capital Management's 13F filing for Q1 2026, filed 1 May 2026.